Sabine Cerny-Reiterer

Sabine Cerny-Reiterer

UNVERIFIED PROFILE

Are you Sabine Cerny-Reiterer?   Register this Author

Register author
Sabine Cerny-Reiterer

Sabine Cerny-Reiterer

Publications by authors named "Sabine Cerny-Reiterer"

Are you Sabine Cerny-Reiterer?   Register this Author

49Publications

2975Reads

15Profile Views

Phenotyping and Target Expression Profiling of CD34/CD38 and CD34/CD38 Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.

Neoplasia 2018 06 15;20(6):632-642. Epub 2018 May 15.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2018.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994777PMC
June 2018

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.

Vet Comp Oncol 2018 Mar 11;16(1):55-68. Epub 2017 Apr 11.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/vco.12311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824979PMC
March 2018

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm.

Wien Klin Wochenschr 2017 Jun 14;129(11-12):404-410. Epub 2016 Oct 14.

Department of Internal Medicine I, Division of Hematology & Hemostaseology, AKH, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-016-1091-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486731PMC
June 2017

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

Clin Cancer Res 2016 Apr 25;22(8):2051-61. Epub 2015 Nov 25.

Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0767DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817228PMC
April 2016

Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.

Am J Blood Res 2014 15;4(2):93-100. Epub 2014 Dec 15.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna Austria ; Department of Dermatology, Medical University of Vienna Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351647PMC
March 2015

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.

Eur J Clin Invest 2014 Dec;44(12):1239-45

Division of Haematology & Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/eci.12368DOI Listing
December 2014

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.

Blood 2014 Jul 27;124(1):111-20. Epub 2014 Mar 27.

Laboratoire de Biologie et Pharmacologie Appliquée, Centre Nationale de la Recherche, Unité Mixte de Recherche 8113, Ecole Normale Supérieure de Cachan, Cachan, France; Laboratoire Central d'Hématologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-10-534685DOI Listing
July 2014

Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.

Clin Cancer Res 2014 Jul 5;20(13):3589-602. Epub 2014 May 5.

Authors' Affiliations: Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2811DOI Listing
July 2014

Cancer stem cell definitions and terminology: the devil is in the details.

Nat Rev Cancer 2012 11 11;12(11):767-75. Epub 2012 Oct 11.

The Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna & Ludwig-Boltzmann Cluster Oncology, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3368DOI Listing
November 2012

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.

Mod Pathol 2011 Apr 24;24(4):585-95. Epub 2010 Dec 24.

Institute of Pathology, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.224DOI Listing
April 2011

Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells.

Best Pract Res Clin Haematol 2010 Sep 12;23(3):369-78. Epub 2010 Aug 12.

Ludwig Boltzmann Cluster Oncology, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2010.07.003DOI Listing
September 2010

Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

Cancer Res 2010 Feb 9;70(4):1513-23. Epub 2010 Feb 9.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Institute of Immunology, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-2181DOI Listing
February 2010